메뉴 건너뛰기




Volumn 4, Issue 8, 2009, Pages 883-893

Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug

Author keywords

Cancer; Carbon nanotubes; Chemotherapeutic drug; Combined chemotherapy; Nano drug delivery; Nanomedicine; Nanotechnology

Indexed keywords

CARBON NANOTUBE; CASPASE 3; ETOPOSIDE; NANOMATERIAL;

EID: 73349118485     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.76     Document Type: Article
Times cited : (71)

References (36)
  • 1
    • 53049104252 scopus 로고    scopus 로고
    • Liu Z, Chen K, Davis C et al.: Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 68 (16), 6652-6660 (2008). ■ Discusses the potential use of carbon nanotubes as carriers of drugs for in vivo cancer treatment.
    • Liu Z, Chen K, Davis C et al.: Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 68 (16), 6652-6660 (2008). ■ Discusses the potential use of carbon nanotubes as carriers of drugs for in vivo cancer treatment.
  • 2
    • 38949105860 scopus 로고    scopus 로고
    • Functionalized carbon nanotubes in drug design and discovery
    • Prato M, Kostarelos K, Bianco A: Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res. 41(1), 60-68 (2008).
    • (2008) Acc. Chem. Res , vol.41 , Issue.1 , pp. 60-68
    • Prato, M.1    Kostarelos, K.2    Bianco, A.3
  • 3
    • 42949087400 scopus 로고    scopus 로고
    • Carbon nanotubes filled with a chemotherapeutic agent: A nanocarrier mediates inhibition of tumor cell growth
    • Hampel S, Kunze D, Haase D et al.: Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomedicine 3(2), 175-182 (2008).
    • (2008) Nanomedicine , vol.3 , Issue.2 , pp. 175-182
    • Hampel, S.1    Kunze, D.2    Haase, D.3
  • 4
    • 0034434229 scopus 로고    scopus 로고
    • Design of two etoposide-amsacrine conjugates: Topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity
    • Arimondo P, Boukarim C, Bailly C et al.: Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. Anticancer Drug Des. 15 (6), 413-421 (2000).
    • (2000) Anticancer Drug Des , vol.15 , Issue.6 , pp. 413-421
    • Arimondo, P.1    Boukarim, C.2    Bailly, C.3
  • 5
    • 0036159856 scopus 로고    scopus 로고
    • Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells
    • Kim JS, Amorino GP, Pyo H et al.: Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiother. Oncol. 62 (1), 61-67 (2002).
    • (2002) Radiother. Oncol , vol.62 , Issue.1 , pp. 61-67
    • Kim, J.S.1    Amorino, G.P.2    Pyo, H.3
  • 6
    • 0037470042 scopus 로고    scopus 로고
    • A two-drug model for etoposide action against human topoisomerase IIα
    • Bromberg KD, Burgin AB, Osheroff N: A two-drug model for etoposide action against human topoisomerase IIα. J. Biol. Chem. 278 (9), 7406-7412 (2003).
    • (2003) J. Biol. Chem , vol.278 , Issue.9 , pp. 7406-7412
    • Bromberg, K.D.1    Burgin, A.B.2    Osheroff, N.3
  • 7
    • 41549130929 scopus 로고    scopus 로고
    • Newer cytotoxic agents: Attacking cancer broadly
    • Teicher BA: Newer cytotoxic agents: attacking cancer broadly. Clin. Cancer Res. 14(6), 1610-1617 (2008).
    • (2008) Clin. Cancer Res , vol.14 , Issue.6 , pp. 1610-1617
    • Teicher, B.A.1
  • 8
    • 0032449143 scopus 로고    scopus 로고
    • Oral etoposide for patients with advanced adenocarcinoma of the pancreas
    • Thomas E, Dumas EP, Ajani JA: Oral etoposide for patients with advanced adenocarcinoma of the pancreas. Invest. New Drugs 16(4), 333-335 (1999).
    • (1999) Invest. New Drugs , vol.16 , Issue.4 , pp. 333-335
    • Thomas, E.1    Dumas, E.P.2    Ajani, J.A.3
  • 9
    • 33751304141 scopus 로고    scopus 로고
    • Emetic potential of daily oral etoposide
    • Brames MJ, Einhorn LH: Emetic potential of daily oral etoposide. Support Care Cancer 14(12), 1262-1265 (2006).
    • (2006) Support Care Cancer , vol.14 , Issue.12 , pp. 1262-1265
    • Brames, M.J.1    Einhorn, L.H.2
  • 10
    • 6344238632 scopus 로고    scopus 로고
    • Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse
    • Hijiya N, Gajjar A, Zhang Z et al.: Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse. Leukemia 18, 1581-1586 (2004).
    • (2004) Leukemia , vol.18 , pp. 1581-1586
    • Hijiya, N.1    Gajjar, A.2    Zhang, Z.3
  • 11
    • 0034654517 scopus 로고    scopus 로고
    • The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis
    • Perkins CL, Guofu F, Caryn KN, Bhalla KN: The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 60, 1645-1653 (2000).
    • (2000) Cancer Res , vol.60 , pp. 1645-1653
    • Perkins, C.L.1    Guofu, F.2    Caryn, K.N.3    Bhalla, K.N.4
  • 12
    • 18644369699 scopus 로고    scopus 로고
    • Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion
    • Stefanelli C, Tantinia B, Fattoria M et al.: Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett. 527(1), 223-228 (2002).
    • (2002) FEBS Lett , vol.527 , Issue.1 , pp. 223-228
    • Stefanelli, C.1    Tantinia, B.2    Fattoria, M.3
  • 13
    • 42649130001 scopus 로고    scopus 로고
    • Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone
    • Smart DJ, Halicka HD, Schmuck G et al.: Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat Res. 641(1-2), 43-47 (2008).
    • (2008) Mutat Res , vol.641 , Issue.1-2 , pp. 43-47
    • Smart, D.J.1    Halicka, H.D.2    Schmuck, G.3
  • 14
    • 0034782735 scopus 로고    scopus 로고
    • p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death
    • Koistinen P, Siitonen T, Mäntymaa P, Savolainen E: p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death. Leukemia Res. 25(12), 1099-1105 (2001).
    • (2001) Leukemia Res , vol.25 , Issue.12 , pp. 1099-1105
    • Koistinen, P.1    Siitonen, T.2    Mäntymaa, P.3    Savolainen, E.4
  • 15
    • 34347228127 scopus 로고    scopus 로고
    • Long term oral etoposide as second line therapy in recurrent epithelial carcinoma of the ovary
    • Moosavi AS, Tehranian A, Behtash N et al.: Long term oral etoposide as second line therapy in recurrent epithelial carcinoma of the ovary. Acta Med. Iran. 44(1), 7-12 (2006).
    • (2006) Acta Med. Iran , vol.44 , Issue.1 , pp. 7-12
    • Moosavi, A.S.1    Tehranian, A.2    Behtash, N.3
  • 16
    • 61649122577 scopus 로고    scopus 로고
    • Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
    • Spitaleri G, Matei DV, Curigliano G et al.: Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer. Ann. Oncol. 20(3), 498-502 (2009).
    • (2009) Ann. Oncol , vol.20 , Issue.3 , pp. 498-502
    • Spitaleri, G.1    Matei, D.V.2    Curigliano, G.3
  • 17
    • 0035106799 scopus 로고    scopus 로고
    • Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer
    • Boyer MJ, Mitchell P, Goldstein D et al.: Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Lung Cancer 32(1), 89 - 94 (2001).
    • (2001) Lung Cancer , vol.32 , Issue.1 , pp. 89-94
    • Boyer, M.J.1    Mitchell, P.2    Goldstein, D.3
  • 18
    • 0344393079 scopus 로고    scopus 로고
    • Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer
    • Morisaki T, Katano M: Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr. Med. Chem. 10(23), 2517-2521 (2003).
    • (2003) Curr. Med. Chem , vol.10 , Issue.23 , pp. 2517-2521
    • Morisaki, T.1    Katano, M.2
  • 19
    • 0035880232 scopus 로고    scopus 로고
    • Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells
    • Li J, Srinivasula M, Feng-Ting L et al.: Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 98(2), 414-421 (2001).
    • (2001) Blood , vol.98 , Issue.2 , pp. 414-421
    • Li, J.1    Srinivasula, M.2    Feng-Ting, L.3
  • 20
    • 0037083593 scopus 로고    scopus 로고
    • Apoptosis induced by low-dose and low-dose-rate radiation
    • Mirzaie-Joniani H, Eriksson D, Sheikholvaezin A et al.: Apoptosis induced by low-dose and low-dose-rate radiation. Cancer 94(4), 1210-1214 (2002).
    • (2002) Cancer , vol.94 , Issue.4 , pp. 1210-1214
    • Mirzaie-Joniani, H.1    Eriksson, D.2    Sheikholvaezin, A.3
  • 21
    • 34147194094 scopus 로고    scopus 로고
    • Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy
    • Seminara P, Pastore C, Iascone C et al.: Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy. Chemotherapy 53(3), 218-225 (2007).
    • (2007) Chemotherapy , vol.53 , Issue.3 , pp. 218-225
    • Seminara, P.1    Pastore, C.2    Iascone, C.3
  • 22
    • 0038080911 scopus 로고    scopus 로고
    • Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors
    • Reddy RK, Mao C, Baumeister P et al.: Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors. J. Biol. Chem. 278(23), 20915-20924 (2003).
    • (2003) J. Biol. Chem , vol.278 , Issue.23 , pp. 20915-20924
    • Reddy, R.K.1    Mao, C.2    Baumeister, P.3
  • 23
    • 0037113881 scopus 로고    scopus 로고
    • Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin
    • Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D: Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J. Biol. Chem. 277(46), 44317-44326 (2002).
    • (2002) J. Biol. Chem , vol.277 , Issue.46 , pp. 44317-44326
    • Panaretakis, T.1    Pokrovskaja, K.2    Shoshan, M.C.3    Grandér, D.4
  • 24
    • 0037334117 scopus 로고    scopus 로고
    • Wen LT, Caldwell CC, Knowles AF: Poly(ADP-ribose)polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells. Mol. Pharmacol. 63(3), 706-713 (2003). ■ ATP (signaling factor) treatment induced a significant increase in apoptotic embryonic kidney cells and was related to the Bax protein expressions.
    • Wen LT, Caldwell CC, Knowles AF: Poly(ADP-ribose)polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells. Mol. Pharmacol. 63(3), 706-713 (2003). ■ ATP (signaling factor) treatment induced a significant increase in apoptotic embryonic kidney cells and was related to the Bax protein expressions.
  • 26
    • 39149109651 scopus 로고    scopus 로고
    • Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator
    • Hwang JH, Kim JY, Cha MI et al.: Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator. J. Cell Physiol. 215(1), 243-250 (2008).
    • (2008) J. Cell Physiol , vol.215 , Issue.1 , pp. 243-250
    • Hwang, J.H.1    Kim, J.Y.2    Cha, M.I.3
  • 27
    • 0035843169 scopus 로고    scopus 로고
    • Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
    • Discusses that metastatic melanomas could have Apaf-1 (cell death effector) inactivated, to mediate apoptosis, ■■
    • Soengas MS, Capodieci P, Polsky D et al.: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-211 (2001). ■■ Discusses that metastatic melanomas could have Apaf-1 (cell death effector) inactivated, to mediate apoptosis.
    • (2001) Nature , vol.409 , pp. 207-211
    • Soengas, M.S.1    Capodieci, P.2    Polsky, D.3
  • 28
    • 0037012034 scopus 로고    scopus 로고
    • Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line
    • Wu GS, Ding Z: Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene 21(1), 1-8 (2002)
    • (2002) Oncogene , vol.21 , Issue.1 , pp. 1-8
    • Wu, G.S.1    Ding, Z.2
  • 29
    • 0034569391 scopus 로고    scopus 로고
    • Inducible resistance to Fas-mediated apoptosis in B cells
    • Rothstein TL: Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res. 10, 245-266 (2000).
    • (2000) Cell Res , vol.10 , pp. 245-266
    • Rothstein, T.L.1
  • 30
    • 25844464705 scopus 로고    scopus 로고
    • Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kb in human keratinocytes
    • Manna SK, Sarkar S, Barr J et al.: Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kb in human keratinocytes. Nano Lett. 5(9), 1676-1684 (2005).
    • (2005) Nano Lett , vol.5 , Issue.9 , pp. 1676-1684
    • Manna, S.K.1    Sarkar, S.2    Barr, J.3
  • 31
    • 3042818668 scopus 로고    scopus 로고
    • Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells
    • Shi Kam NW, Jessop TC, Wender PA et al.: Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 22(126), 6850-6851 (2004).
    • (2004) J. Am. Chem. Soc , vol.22 , Issue.126 , pp. 6850-6851
    • Shi Kam, N.W.1    Jessop, T.C.2    Wender, P.A.3
  • 32
    • 31944451232 scopus 로고    scopus 로고
    • Toxic potential of materials at the nanolevel
    • Andre N, Tian X, Lutz M, Ning L: Toxic potential of materials at the nanolevel. Science 311, 622-627 (2006).
    • (2006) Science , vol.311 , pp. 622-627
    • Andre, N.1    Tian, X.2    Lutz, M.3    Ning, L.4
  • 33
    • 40349112868 scopus 로고    scopus 로고
    • Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy
    • Describes the biodistribution of carbon nanotubes into various organs and tissues based on their unique Raman signature, ■■
    • Liu Z, Davis C, Cai W, He L, Chen X, Dai H: Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA 105(5), 1410-1415 (2008). ■■ Describes the biodistribution of carbon nanotubes into various organs and tissues based on their unique Raman signature.
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , Issue.5 , pp. 1410-1415
    • Liu, Z.1    Davis, C.2    Cai, W.3    He, L.4    Chen, X.5    Dai, H.6
  • 34
    • 58149293968 scopus 로고    scopus 로고
    • Quantum dots as multimodal photoacoustic and photothermal contrast agents
    • Shashkov EV, Everts M, Galanzha EI, Zharov VP: Quantum dots as multimodal photoacoustic and photothermal contrast agents. Nano Lett. 8(11), 3953-3958 (2008).
    • (2008) Nano Lett , vol.8 , Issue.11 , pp. 3953-3958
    • Shashkov, E.V.1    Everts, M.2    Galanzha, E.I.3    Zharov, V.P.4
  • 35
    • 67349198099 scopus 로고    scopus 로고
    • Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel
    • Feng SS, Mei L, Anitha P, Gan CW, Zhou W: Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials 30, 3297-3306 (2009).
    • (2009) Biomaterials , vol.30 , pp. 3297-3306
    • Feng, S.S.1    Mei, L.2    Anitha, P.3    Gan, C.W.4    Zhou, W.5
  • 36
    • 20444416355 scopus 로고    scopus 로고
    • Poly(D,L-lactide-coglycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
    • Dong Y, Feng SS: Poly(D,L-lactide-coglycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 6068-6076 (2005).
    • (2005) Biomaterials , vol.26 , pp. 6068-6076
    • Dong, Y.1    Feng, S.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.